Agomab Therapeutics, an Asabys portfolio company, debuts on Nasdaq

by Asabys Partners

The relationship with the company began in 2021, when Agomab acquired Origo Biopharma, one of their portfolio companies, marking Asabys’s first exit. Since then, they have continued to support Agom...

Read more

Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac®

by Asabys Partners

Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational Life Sciences Corporation, bringing additional resources and strategic expertis...

Read more

El CDTI Innovación invierte, junto con ASABYS y Criteria Bio Ventures, en MEDLUMICS, S.L., compañía dedicada al desarrollo de dispositivos médicos basados en alta tecnología

by CDTI Innovación

MedLumics es una empresa de dispositivos médicos que desarrolla AblaView®, el primer sistema de catéter de ablación en tiempo real guiado ópticamente para el tratamiento de la fibrilación auricu...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream